What does biological aging rate measure in my DNA?

Your biological aging rate result reflects genetic variants that influence GrimAge acceleration — how quickly your DNA methylation patterns shift toward those associated with aging and mortality risk. GrimAge is an epigenetic clock trained on time-to-death data, making it among the most mortality-predictive molecular aging measures available. A higher score means a genetic predisposition toward faster accumulation of age-associated methylation changes.

Is biological aging rate the same as chronological age?

No. Chronological age is simply how many years you have lived. Biological aging rate measures how quickly your body accumulates molecular aging changes — and individuals of the same chronological age can differ by a decade or more in GrimAge-estimated biological age. GrimAge acceleration specifically measures the excess biological age above chronological age, and it predicts mortality risk and age-related morbidity better than chronological age alone.

Why is the F2RL3 gene important for biological aging?

F2RL3 encodes a platelet receptor whose CpG methylation site (cg03636183) serves as a molecular proxy for cumulative tobacco smoke exposure. The GrimAge clock incorporates F2RL3 methylation specifically because smoking methylates this site in a dose-dependent manner — effectively encoding pack-years of smoking into the epigenetic age estimate. Variants in F2RL3 affect baseline methylation at this site, influencing how strongly smoking history registers in GrimAge calculations.

What is the connection between POU5F1 and aging reversal research?

POU5F1 encodes OCT4, one of the four Yamanaka reprogramming factors that can reset adult cells to a stem-cell-like state. In aging, epigenetic silencing of POU5F1 and related pluripotency genes progressively erodes. Partial reprogramming experiments using the Yamanaka factors — including OCT4 — have demonstrated reversal of epigenetic aging clock readings in cells and some tissue contexts, placing POU5F1 at the frontier of aging reversal science.

Can I slow my biological aging rate through lifestyle changes?

Yes. Genetics accounts for approximately 20-30% of GrimAge acceleration variance, meaning lifestyle factors drive the majority. Smoking cessation has the largest single documented effect on GrimAge. Regular exercise, time-restricted eating, adequate sleep, stress management, and methyl-donor nutrition (folate, B12, betaine, choline) each have evidence supporting measurable reductions in epigenetic aging clock rates.

How is this biological aging rate trait different from a general aging trait?

This trait specifically covers GrimAge methylation clock acceleration — a mortality-trained epigenetic aging measure. It is genetically and mechanistically distinct from general aging GWAS results: GrimAge uses unique CpG sites including F2RL3 (a smoking biomarker) and POU5F1 (a pluripotency locus), and its associated genes differ from general aging loci such as APOE or COL1A2. GrimAge predicts time-to-death more accurately than clocks trained on chronological age matching.

Biological Aging Rate and Your Genetics

By the ExomeDNA Science Team | This page contains general information only. For personal health decisions, consult a qualified clinician.

Biological aging rate — the speed at which your body ages at the molecular level — is one of the most consequential metrics in modern longevity research, and your DNA plays a measurable role in shaping it. The GrimAge methylation clock, a DNA-based measure of biological aging, tracks how quickly your body accumulates the epigenetic marks associated with age-related decline and mortality risk. Below: how GrimAge works, the six genes linked to its acceleration, what the science shows, and six evidence-based levers you can act on today.

What is biological aging rate?

Biological aging rate refers to how quickly the body undergoes the molecular changes associated with aging — changes that often diverge substantially from chronological age. Two people born in the same year can differ by a decade or more in biological age as measured by validated molecular clocks.

The most widely studied molecular tool for quantifying biological aging rate is the GrimAge clock, developed by Steve Horvath and colleagues. Unlike earlier epigenetic clocks (such as the original Horvath clock or the Hannum clock), GrimAge was specifically trained to predict time-to-death and age-related morbidity rather than just chronological age. This makes it among the most mortality-predictive epigenetic aging measures available.

GrimAge works by measuring DNA methylation — chemical tags (methyl groups) attached to cytosine bases in DNA at specific CpG sites. Methylation patterns shift predictably over a lifetime, and GrimAge tracks a curated set of these shifts, including methylation proxies for smoking exposure, plasma proteins associated with aging, and other biological signals. When GrimAge estimates an individual's biological age as older than their chronological age, that excess — called GrimAge acceleration — is associated with increased mortality risk, cardiovascular disease, cognitive decline, and reduced healthspan.

Your ExomeDNA result for this trait reflects genetic variants that influence your predisposition toward faster or slower GrimAge acceleration, independent of lifestyle factors.

The genetics behind biological aging rate

Large-scale genome-wide association studies (GWAS) have identified genetic loci that influence DNA methylation patterns underlying epigenetic aging clocks. A landmark 2021 study by McCartney and colleagues (PMID 34187551) analyzed data from more than 40,000 individuals and identified 137 genetic loci associated with DNA methylation biological age measures, including GrimAge. A 2022 study by Lin and colleagues (PMID 34962275) extended this by examining four distinct epigenetic age acceleration measures in genome-wide analyses, refining understanding of the genetic architecture underlying biological aging.

Six genes connect your genetics to GrimAge acceleration through distinct biological mechanisms:

POU5F1 (OCT4) is the master pluripotency transcription factor — one of the four Yamanaka reprogramming factors (alongside SOX2, KLF4, and c-MYC) capable of resetting adult cells to a stem-cell-like state. In healthy adult somatic tissue, POU5F1 expression is epigenetically silenced. With aging, the stability of this silencing degrades progressively, and CpG methylation at POU5F1-associated sites is incorporated into epigenetic aging measurements. This gene represents perhaps the most scientifically compelling link between GrimAge acceleration and the frontier of aging reversal research: partial reprogramming experiments using Yamanaka factors — including OCT4 — have demonstrated reversal of epigenetic aging clock readings in cells and some tissue contexts, making POU5F1 a focal point for longevity science.

F2RL3 encodes protease-activated receptor 4 (PAR4), a thrombin-activated receptor on platelets. The CpG site cg03636183 within F2RL3 is one of the components of the GrimAge clock specifically because its methylation level serves as a dose-dependent molecular proxy for cumulative tobacco smoke exposure — pack-years of smoking. Cigarette smoke methylates F2RL3 in a quantifiable manner, and GrimAge incorporates this signal to reflect accumulated smoking damage in its biological age estimate. Genetic variants in F2RL3 affect both baseline methylation at this site and PAR4-mediated platelet activation, connecting biological aging rate to cardiovascular risk pathways.

IBA57 encodes an iron-sulfur cluster assembly factor required for the biosynthesis of [4Fe-4S] clusters in mitochondria. These iron-sulfur clusters are essential redox cofactors for respiratory chain complexes I, II, and III — the machinery that generates ATP through oxidative phosphorylation. IBA57 mutations in humans cause multiple mitochondrial dysfunction syndrome, a severe condition illustrating how central this protein is to mitochondrial health. With aging, iron-sulfur cluster degradation and impaired replacement reduces mitochondrial electron transport efficiency, driving increased reactive oxygen species production and reduced energy output. IBA57 variants that affect Fe-S cluster assembly efficiency connect GrimAge acceleration directly to the mitochondrial aging axis — one of the most mechanistically grounded theories of biological aging.

CAPN3 encodes calpain 3, a calcium-dependent cysteine protease expressed predominantly in skeletal muscle. Loss-of-function mutations in CAPN3 cause limb-girdle muscular dystrophy 2A, demonstrating its essential role in muscle integrity. Calpain proteases regulate skeletal muscle protein turnover, and skeletal muscle aging — sarcopenia — is one of the most reliable biological aging biomarkers and a GrimAge-correlated phenotype. CAPN3 variants affecting muscle protein homeostasis likely influence biological aging rate through their impact on muscle mass maintenance and cellular senescence in muscle tissue.

CYTIP encodes cytohesin-interacting protein, a scaffolding protein for cytohesin guanine-nucleotide exchange factors (GEFs). CYTIP regulates integrin activation and lymphocyte trafficking — processes central to immune cell adhesion and immune surveillance. Aging is accompanied by progressive changes in immune cell composition and function (immunosenescence), and alterations in integrin-mediated immune trafficking are part of this process. CYTIP variants may influence biological aging rate through effects on immune system aging.

MED24 encodes mediator complex subunit 24, a component of the Mediator transcriptional co-activator complex that integrates signals from transcription factors to RNA polymerase II at gene promoters. The Mediator complex is a master regulator of gene expression programs, and age-related shifts in Mediator complex activity affect the transcriptional landscape of aging cells. MED24 variants may influence biological aging rate through effects on the fidelity of aging-relevant gene expression programs.

What the research says

Research base: Robust.

The genetics of epigenetic aging rate is an area of active and productive research. Two key findings anchor this trait:

Study 1 — McCartney et al. 2021 (PMID 34187551): This genome-wide association study of DNA methylation biological age measures across more than 40,000 participants identified 137 genetic loci associated with epigenetic age acceleration. The study confirmed substantial heritable components to GrimAge acceleration and identified biologically plausible gene sets including those involved in transcriptional regulation, immune function, and mitochondrial biology. Heritability estimates for GrimAge acceleration ranged from approximately 20–30% in twin studies, indicating that while genetics shapes predisposition, the majority of variance is attributable to environmental and lifestyle exposures.

Study 2 — Lin et al. 2022 (PMID 34962275): A genome-wide association study of four epigenetic age acceleration measures — including GrimAge acceleration — identified novel loci and refined understanding of genetic overlap between different aging clocks. The study demonstrated that distinct clocks capture partially non-overlapping genetic signals, supporting the view that GrimAge acceleration reflects a biologically distinct dimension of aging (mortality-related) compared to clocks trained on chronological age matching.

Key quantitative context:

GrimAge acceleration of +5 years is associated with approximately 29% higher all-cause mortality hazard in prospective studies
Smoking is the single largest environmental contributor to GrimAge acceleration, adding an estimated 2–4 years of biological age per decade of smoking
Heritability of GrimAge acceleration: approximately 20–30% — meaning genetics accounts for roughly one-quarter of individual differences, with lifestyle accounting for the majority
Physical exercise has been shown to reduce GrimAge biological age by 1–3 years in intervention studies
Time-restricted eating and caloric restriction slow epigenetic aging clock rates in multiple human and animal studies

The GrimAge clock outperforms earlier epigenetic clocks in predicting mortality, age-related morbidity, and physical and cognitive decline, establishing it as the most clinically relevant epigenetic aging measure available.

How biological aging rate affects you

GrimAge acceleration — an elevated biological aging rate relative to chronological age — is associated with a broad spectrum of age-related outcomes:

Cardiovascular health. GrimAge acceleration correlates with higher rates of coronary artery disease, stroke, and hypertension. The F2RL3/PAR4 pathway connects biological aging rate directly to platelet activation and thrombosis risk, one mechanistic route through which GrimAge acceleration maps onto cardiovascular outcomes.

Cognitive function. Higher GrimAge acceleration is associated with accelerated cognitive decline and increased risk of dementia in prospective cohort data. Epigenetic aging in brain tissue parallels peripheral blood GrimAge measures, supporting a systemic rather than tissue-specific mechanism.

Physical capacity. GrimAge acceleration correlates with reduced grip strength, slower walking speed, lower VO2 max, and earlier onset of sarcopenia — the age-related loss of skeletal muscle mass connected to the CAPN3 pathway.

Immune resilience. Faster biological aging is associated with immunosenescence — reduced immune surveillance, higher chronic low-grade inflammation (inflammaging), and impaired vaccine response.

Metabolic health. GrimAge acceleration correlates with insulin resistance, metabolic syndrome, and reduced metabolic flexibility.

A genetic predisposition toward higher GrimAge acceleration does not mean these outcomes are inevitable — it means the biological systems underlying aging may operate under greater baseline pressure, making lifestyle optimization correspondingly more impactful.

Working with your biological aging rate result

Because lifestyle factors account for roughly 70–80% of GrimAge acceleration variance, genetics establishes a floor but not a ceiling. The following interventions have the strongest evidence for reducing GrimAge acceleration:

Stop smoking. Smoking is the most potent single accelerant of GrimAge, operating directly through F2RL3 methylation — a built-in component of the clock. Cessation is associated with partial reversal of F2RL3 methylation over years, measurably reducing biological age acceleration. No other single intervention has a larger documented effect size on GrimAge.
Prioritize structured exercise. Regular aerobic and resistance exercise reduces GrimAge acceleration through multiple pathways: stimulating mitochondrial biogenesis (relevant to IBA57/Fe-S cluster biology), reducing inflammaging, supporting muscle mass (relevant to CAPN3/sarcopenia), and improving immune surveillance. Multiple intervention trials show 1–3 years of biological age improvement with sustained exercise programs.
Consider time-restricted eating or moderate caloric restriction. These nutritional strategies consistently slow epigenetic aging clock rates in human studies. Even a 10–14 hour eating window has shown measurable GrimAge effects in randomized trials.
Protect sleep quality and duration. Insufficient or disrupted sleep accelerates GrimAge. Seven to nine hours of consistent, high-quality sleep is associated with slower biological aging across multiple cohort studies.
Manage chronic psychological stress. Chronic stress is an independent accelerant of GrimAge, likely operating through glucocorticoid-mediated epigenetic remodeling and inflammaging. Mindfulness-based stress reduction and other behavioral interventions show modest but measurable epigenetic aging effects.
Support methylation capacity through nutrition. DNA methylation maintenance — the core mechanism GrimAge tracks — depends on methyl-donor availability: folate, vitamin B12, betaine, and choline are dietary precursors to S-adenosylmethionine (SAM), the universal methyl donor. Adequate intake of these nutrients supports the epigenetic maintenance machinery whose age-related decline GrimAge measures.

If your result indicates elevated GrimAge acceleration predisposition, these six levers represent the highest-leverage, evidence-based points of intervention. The relative gain from each intervention may be amplified for those with higher genetic predisposition.

Biological aging rate intersects with several adjacent traits and genetic pathways in the ExomeDNA report:

The Mitochondrial Function traits share the IBA57/Fe-S cluster biology axis — mitochondrial dysfunction is both a cause and a consequence of accelerated biological aging. The Cardiovascular Risk category connects through F2RL3/PAR4-mediated platelet activation and the shared cardiovascular correlates of GrimAge acceleration. Muscle Strength and Composition traits share the CAPN3/sarcopenia axis. The Inflammation category shares the inflammaging biology that drives and is driven by epigenetic aging acceleration.

Key authorized genes for this trait — CAPN3, CYTIP, F2RL3, IBA57, MED24, and POU5F1 — each operate in distinct biological compartments (muscle, immune trafficking, platelets, mitochondria, transcription, and pluripotency/epigenetic maintenance), reflecting the multi-system nature of biological aging.

Importantly, this trait is distinct from general aging GWAS results: GrimAge acceleration specifically captures methylation-clock-based biological aging trained on mortality outcomes, with POU5F1 and F2RL3 as mechanistically unique components not shared with general aging loci such as APOE or COL1A2.

Frequently asked questions

References

McCartney DL et al. Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging. Genome Biology. 2021. PMID 34187551.
Lin WY et al. Genome-wide association study for four measures of epigenetic age acceleration and their interactions with lifestyle factors. GeroScience. 2022. PMID 34962275.

--- ExomeDNA genetic results are for wellness and educational purposes only. Consult a clinician for personalized health guidance.

Browse all traits →